Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mammary Neoplasms, Human”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT04060342
What this trial is testing

GB1275 Monotherapy and in Combination With an Anti-PD1 Antibody in Patients With Specified Advanced Solid Tumors or in Combination With Standard of Care in Patients With Metastatic Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic AdenocarcinomaEsophageal AdenocarcinomaEsophageal Squamous Cell Carcinoma+11 more
GB006, Inc., a wholly owned subsidiary of Gossamer Bio, Inc. 61
Large-scale testing (Phase 3)Looking for participantsNCT03201861
What this trial is testing

Addition of Cisplatin to Adjuvant Chemotherapy for Early Stage Breast Cancer in High-Risk Women

Who this might be right for
Tubular Breast CancerMucinous Breast CancerInvasive Duct Carcinoma of Breast
RenJi Hospital 762
Early research (Phase 1)Study completedNCT02527746
What this trial is testing

Study of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy

Who this might be right for
NeutropeniaBreast Cancer
EVIVE Biotechnology 18
Early research (Phase 1)UnknownNCT02140996
What this trial is testing

Safety Study of Human MUC-1 (Mucin-1) Adenoviral Vector Vaccine for Immunotherapy of Epithelial Cancers

Who this might be right for
Epithelial Cancers of the Lung, Breast, Ovary, Prostate and Colon
Singapore Clinical Research Institute 24
Not applicableStudy completedNCT04227613
What this trial is testing

Aspects of Breast-conserving Surgery

Who this might be right for
Breast NeoplasmCosmetic OutcomeQuality of Life
Lund University 351
Large-scale testing (Phase 3)Active Not RecruitingNCT04305496
What this trial is testing

Capivasertib+Fulvestrant vs Placebo+Fulvestrant as Treatment for Locally Advanced (Inoperable) or Metastatic HR+/HER2- Breast Cancer

Who this might be right for
Locally Advanced (Inoperable) or Metastatic Breast Cancer
AstraZeneca 818
Testing effectiveness (Phase 2)Study completedNCT01031446
What this trial is testing

Cisplatin, Paclitaxel, and Everolimus in Treating Patients With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Vanderbilt-Ingram Cancer Center 55
Testing effectiveness (Phase 2)Active Not RecruitingNCT02834013
What this trial is testing

Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

Who this might be right for
Acinar Cell CarcinomaAdenoid Cystic CarcinomaAdrenal Cortical Carcinoma+91 more
National Cancer Institute (NCI) 798
Not applicableStudy completedNCT04736576
What this trial is testing

Study to Evaluate Patient Reported Outcome (PRO) and Physical Activity in Japanese Patients With HR+/HER2- Advanced Breast Cancer Treated With Palbociclib Plus Endocrine Therapy or Endocrine Monotherapy

Who this might be right for
Breast Cancer
Pfizer 99
Testing effectiveness (Phase 2)Study completedNCT03671330
What this trial is testing

Efficacy and Safety of Ribociclib in Pre- and Postmenopausal Chinese Women With HR Positive, HER2-negative, Advanced Breast Cancer.

Who this might be right for
Breast Cancer
Novartis Pharmaceuticals 327
Testing effectiveness (Phase 2)Active Not RecruitingNCT04721977
What this trial is testing

Tucatinib (MK-7119) in Combination With Trastuzumab and Capecitabine in Participants With Previously Treated Locally Advanced Unresectable or Metastatic Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Breast Carcinoma (MK-7119-001)

Who this might be right for
Breast Cancer
Pfizer 66
Early research (Phase 1)Ended earlyNCT05827614
What this trial is testing

Study of the CHK1 Inhibitor BBI-355, an ecDNA-directed Therapy (ecDTx), and the RNR Inhibitor BBI-825, in Subjects With Tumors With Oncogene Amplifications

Who this might be right for
Triple Negative Breast Cancer (TNBC)High Grade Serous Ovarian CarcinomaHigh Grade Endometrial Carcinoma+9 more
Boundless Bio, Inc. 85
Early research (Phase 1)Study completedNCT02009449
What this trial is testing

Pegilodecakin (LY3500518) in Participants With Advanced Solid Tumors

Who this might be right for
MelanomaProstate CancerOvarian Cancer+6 more
Eli Lilly and Company 353
Testing effectiveness (Phase 2)Looking for participantsNCT06348134
What this trial is testing

Assessing the Efficacy and Safety of Anti-HER2 Therapy in Nigerian Women With HER2+ Breast Cancer Before and After Surgery

Who this might be right for
Human Epidermal Growth Factor 2 Negative Carcinoma of BreastHER2-positive Breast CancerBreast Cancer
University of Chicago 74
Testing effectiveness (Phase 2)Study completedNCT00637026
What this trial is testing

Ph II Early BC Pre-Surgical Biologic Study

Who this might be right for
Breast Cancer
AstraZeneca 65
Testing effectiveness (Phase 2)Ended earlyNCT04441099
What this trial is testing

NBE-002 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorAdvanced CancerTriple Negative Breast Cancer
NBE-Therapeutics AG 12
Not applicableUnknownNCT06264934
What this trial is testing

An Investigation Into Dielectric Assessment of Permittivity and Conductivity in Human Using a Novel Electrical Capacitance Tomography Scanner

Who this might be right for
Breast CancerBenign Breast Disease
Zedsen Limited 90
Testing effectiveness (Phase 2)UnknownNCT02934828
What this trial is testing

Study of Preoperative Chemotherapy for Early Triple Negative or HER2-positive Operable Breast Cancer

Who this might be right for
Breast Cancer
Chinese Academy of Medical Sciences 230
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07581314
What this trial is testing

Oral Zn-Telomir Monotherapy in Patients With Advanced or Metastatic Triple-Negative Breast Cancer (TNBC)

Who this might be right for
Triple-Negative Breast Cancer (TNBC)Advanced Triple-Negative Breast CancerMetastatic Triple-negative Breast Cancer
Telomir Pharmaceuticals, Inc. 76
Testing effectiveness (Phase 2)Study completedNCT04143711
What this trial is testing

Study of DF1001 in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumor, Adult
Dragonfly Therapeutics 270
Next Page